TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lu, Ming ^a   Tian, Hui ^a   Yue, Weiming ^a   Li, Lin ^a   Li, Shuhai ^a   Qi, Lei ^a   Hu, Wensi ^a   Gao, Cun ^a   Si, Libo ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BRF2; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UNIVARIATE ANALYSIS; WESTERN BLOTTING;

AGED; ANTIGENS, CD34; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECURRENCE; TRANSCRIPTION FACTOR TFIIIB; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84895748013     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088032     Document Type: Article

References (24)

1. Rooney C, Sethi T (2011) The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration 81: 89-104.
2. Brognard J, Clark AS, Ni Y, Dennis PA (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 61:3986-3997. (Pubitemid 32720961)
3. Ren H, Tang X, Lee JJ, Feng L, Everett DA, et al. (2004) Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol 22: 3230-3237. (Pubitemid 41103677)
4. Flehinger BJ, Kimmel M, Melamed MR (1992) The effect of surgical treatment on survival from early lung cancer: implications for screening. Chest 101:1013-1018.
5. Fry WA, Philips JL and Menck HR (1999) Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86:1867-1876.
6. Crinò L, Weder W, van Meerbeeck J, Felip E, ESMO Guidelines Working Group (2011) Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21: v103-115.
7. Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nature Struct. Mol. Biol 13:1097-1101. (Pubitemid 44885920)
8. Schramm L, Hernandez N (2002) Recruitment of RNA polymerase III to its target promoters. Genes Dev 16: 2593-2620.
9. Wang T, Lv M, Shen S, Zhou S, Wang P, et al. (2012) Cell-Free MicroRNA Expression Profiles in Malignant Effusion Associated with Patient Survival in Non-Small Cell Lung Cancer. PLoS One 7: e43268.
10. Felton-Edkins ZA, Kenneth NS, Brown TR, Daly NL, Gomez-Roman N, et al. (2003) Direct regulation of RNA polymerase III transcription by RB, p53 and c-Myc. Cell Cycle 2: 181-184.
11. Johnson SS, Zhang C, Fromm J, Willis IM, Johnson DL (2007) Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol Cell 26:367-379. (Pubitemid 46687096)
12. Reina JH, Azzouz TN, Hernandez N (2006) Maf1, a New Player in the Regulation of Human RNA Polymerase III Transcription. PLoS ONE 1:e134.
13. Rollins J, Veras I, Cabarcas S, Willis I, Schramm L (2007) Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int J Biol Sci 3(5):292-302. (Pubitemid 46707827)
14. Goodfellow SJ, Graham EL, Kantidakis T, Marshall L, Coppins BA, et al. (2008) Regulation of RNA Polymerase III Transcription by Maf1 in Mammalian Cells. J Mol Biol 378(2):481-91.
15. Jacob J, Cabarcas S, Veras I, Zaveri N, Schramm L (2007) The green tea component EGCG inhibits RNA polymerase III transcription. Biochem Biophys Res Commun 360(4):778-783. (Pubitemid 47077389)
16. Cabarcas S, Schramm L (2011) RNA polymerase III transcription in cancer: the BRF2 connection. Molecular Cancer 10(1):47-57.
17. Lu M, Tian H, Yue W, Li L, Li S, et al. (2013) Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer [J]. Medical Oncology, 30(2): 1-9.
18. Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, et al. (2010) Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma. PLoS Med 7(7):e1000315.
19. Li S-h, Tian H, Yue W-m, Li L, Li W-j, et al. (2011) Overexpression of Metastasis-Associated Protein 1 is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Early-Stage Non-Small Cell Lung Cancer. Ann Surg Oncol 18:2048-2056.
20. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, et al. (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer38:1564-1579. (Pubitemid 34876495)
21. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, et al. (2005) The Expression of the Regulatory T Cell-Specific Forkhead Box Transcription Factor FoxP3 Is Associated with Poor Prognosis in Ovarian Cancer. Clinical cancer research 11: 8326-8331. (Pubitemid 41746944)
22. Geiduschek EP, Kassavetis GA (2001) The RNA polymerase III transcription apparatus. J Mol Biol 310(1):1-26. (Pubitemid 32621715)
23. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networksin a collection of 18,000 cancer gene expression profiles. Neoplasia 9(2):166-80.
24. Urbich C, Kuehbacher A, Dimmeler S (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research 79:581-588.